BackJupiter Neurosciences- Warrants(19/11/2026) Overview

Jupiter Neurosciences- Warrants(19/11/2026) Net Income

Jupiter Neurosciences- Warrants(19/11/2026)'s net income is $-9.2M, below the sector sector average of $110M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$2.06M
34.87% YoY

As of Mar 2026

Annual Net Income (TTM)

-$9.18M
175.25% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Jupiter Neurosciences- Warrants(19/11/2026) (JUNSW) FAQ

Jupiter Neurosciences- Warrants(19/11/2026) posts a net income of $-9.2M as of March 2026. That compares with $-3.3M in the prior-year period — down 175.3% year over year. That is below the sector sector average of $110M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Jupiter Neurosciences- Warrants(19/11/2026)'s net income was $-3.3M. The latest reading is $-9.2M — a 175.3% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a net income near $110M is typical. Jupiter Neurosciences- Warrants(19/11/2026)'s $-9.2M is lower that level. That is roughly 108.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Net Income is one piece of Jupiter Neurosciences- Warrants(19/11/2026)'s financial statement story. At $-9.2M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for JUNSW's net income usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $110M), and (3) consistency with growth and profitability. This page covers the first two; Jupiter Neurosciences- Warrants(19/11/2026)'s other metric pages and overview cover the third.